Evaluation of DNA Repair Gene XRCC1 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk |
Li, Qiu-Wen
(Oncology Department, No 1 Hospital Affiliated to the General Hospital of the Chinese People's Liberation Army)
Lu, Can-Rong (General Hospital of the Chinese People's Liberation Army) Ye, Ming (Oncology Department, No 1 Hospital Affiliated to the General Hospital of the Chinese People's Liberation Army) Xiao, Wen-Hua (Oncology Department, No 1 Hospital Affiliated to the General Hospital of the Chinese People's Liberation Army) Liang, Jun (Department of Oncology, the Affiliated Hospital, Medical College of Qingdao University) |
1 | Yu MW, Yang SY, Pan IJ, et al (2003). Polymorphisms in XRCCl and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular Carcinoma. J Natl Cancer Inst, 95, 1485-8. DOI |
2 | Zipprich J, Terry MB, Brandt-Rauf P, et al (2010). XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. J Carcinog, 9, 4. DOI |
3 | Ott K, Rachakonda PS, Panzram B, et al (2011). DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ann Surg Oncol, 18, 2688-98. DOI |
4 | Pan HZ, Liang J (2011). XRCC1-Arg399Gln of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev, 12, in press. |
5 | Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8. |
6 | Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48. DOI |
7 | Rybarova S, Vecanova J, Hodorova I, et al (2011). Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit, 17, BR354-63. |
8 | Sakano S, Wada T, Matsumoto H, et al (2006). Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer, 95, 561-70. DOI |
9 | Thompson LH, Brookman KW, Jones NJ, et al (1990). Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol, 10, 6160-71. DOI |
10 | Tudek B (2007). Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med, 28, 258-75. DOI |
11 | Yin M, Tan DF, Wei QY (2009). Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: a metaanalysis. Int J Clin Exp Med, 2, 26-35. |
12 | Yu HP, Zhang XY, Wang XL, et al (2004). DNA repair gene XRCC1 polymorphisms, smoking and esophageal cancer risk. Cancer Detect Prev, 28, 194-9. DOI |
13 | Grimminger PP, Brabender J, Warnecke-Eberz U, et al (2010). XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer. J Surg Res, 164, e61-6. DOI |
14 | Kiyohara C, Takayama K, Nakanishi Y (2010). Lung cancer risk and genetic polymorphisms in DNA repair pathways: A meta-analysis. J Nucleic Acids, 2010,701760. |
15 | Han J, Hankinson SE, Colditz GA, et al (2004). Genetic variation in XRCC1, sun exposure and risk of skin cancer. Br J Cancer, 91, 1604-9. DOI |
16 | International Agency for Research on Cancer: Liver Cancer Incidence and Mortality Worldwide in 2008. 2011, http://globocan.iarc.fr/factsheets/cancers/liver.asp |
17 | Ishii H, Kurose I, Kato S (1997). Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress. J Gastroenterol Hepatol, 12, S272-82. DOI |
18 | Kiran M, Saxena R, Chawla YK, et al (2009). Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem, 327, 7-13. DOI |
19 | Liu F, Li B, Wei Y, et al (2011). XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a metaanalysis. Liver Int, 31, 802-9. DOI |
20 | Long XD, Ma Y, Zhou YF, Ma AM, Fu GH (2010). Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology, 52, 1301-9. DOI |
21 | Navasumrit P, Ward TH, Dodd NJ, et al (2000). Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: effects of acute and chronic ethanol exposure. Carcinogenesis, 21, 93-9. DOI |
22 | Nordmann R, Ribiere C, Rouach H (1992). Implication of free radical mechanisms in ethanol-induced cellular injury. Radic Biol Med, 12, 219-40. DOI |
23 | Clot P, Tabone M, Arico S, et al (1994). Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut, 35, 1637-43. DOI |
24 | Ang MK, Patel MR, Yin XY, et al (2010). Expression and prognostic significance of X-ray crosscomplementation group 1 (XRCC1) in head and neck squamous cell carcinoma patients undergoing concurrent chemoradiation. J Clin Oncol, suppl, 5541. |
25 | Audebert M, Salles B, Calsou P (2004). Involvement of poly(- ADP-ribose)polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem, 279, 117-26. DOI |
26 | Basso D, Navaglia F, Fogar P, et al (2007). DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta, 381, 50-5. DOI |
27 | Geng J, Zhang YW, Huang GC, et al (2008). XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A metaanalysis. World J Gastroenterol, 14, 6733-7. DOI |